Stock Price, News, Quote and Profile of REVVITY INC(NYSE:RVTY) stock

REVVITY INC

NYSE:RVTY (12/20/2024, 8:04:01 PM)

After market: 112.56 0 (0%)

112.56

+2.02 (+1.83%)

Chartmill TA Rating

Chartmill Setup Rating

Sector

GICS SectorHealth Care

GICS IndustryLife Sciences Tools & Services

GICS SubIndustryLife Sciences Tools & Services

Chartmill FA Rating

Valuation

Growth

Profitability

Health

Dividend

Chartmill High Growth Momentum

EPS Q2Q%8.47%

Sales Q2Q%1.98%

CRS41.27

6 Month4.24%

Overview

Earnings (Last)11-04 2024-11-04/bmo

Earnings (Next)01-30 2025-01-30/amc

Ins Owners0.23%

Inst Owners90.94%

Market Cap13.70B

Shares121.70M

PE23.8

Fwd PE21.6

Dividend Yield0.25%

Analysts77.04

Short Float %3.55%

Short Ratio4.7

IPO07-06 1965-07-06

Stock Screener Links

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

GICS Sector Stock Screener

Find competitors from the same sector on the USA

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

Company Profile

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. The company is headquartered in Waltham, Massachusetts and currently employs 11,500 full-time employees. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The Life Sciences Segment applications include MicroBeta, The MuviCyte live-cell imaging system, The Signals Image Artist, The VICTOR Nivo multimode plate reader benchtop system, The EnSight multimode plate reader benchtop system, BioLegend LEGENDplex bead-based reagents, and The Quantum GX2 system. Its Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The company offers instruments, reagents, assay platforms and software to hospitals, and medical labs. The company is focused on reproductive health, immunodiagnostics, and emerging market diagnostics.